| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $23.51M | - | |
| 10% | 5.61M | $12.77M | - | |
| CFO | 100.0K | $227.5K | - | |
| CEO | 100.0K | $227.5K | - | |
| Other | 100.0K | $227.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2018 | Shlevin Harold H.89 | Chief Operating Officer | Sale+OE | 43,698 | $7.41 | $323,986.15 | -89.0% | |
| Jun 12, 2018 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 9,294 | $7.01 | $65,166.74 | -88.1% | |
| Jun 11, 2018 | Shlevin Harold H.89 | Chief Operating Officer | Sale+OE | 115,054 | $5.84 | $671,987.54 | -71.0% | |
| Jun 11, 2018 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 120,000 | $5.85 | $702,500.00 | -97.9% | |
| Jun 8, 2018 | Czirr James C | - | Sell | 110,000 | $5.88 | $646,800.00 | -1.8% | |
| Jun 8, 2018 | 10x Fund, L.P.85 | - | Sell | 110,000 | $5.88 | $646,800.00 | -1.8% | |
| Jun 8, 2018 | Traber Peter G59 | President &CEO | Sale+OE | 70,000 | $5.86 | $409,997.00 | -39.5% | |
| Jun 7, 2018 | Shlevin Harold H.89 | Chief Operating Officer | Sale+OE | 109,969 | $5.20 | $572,020.51 | -50.5% | |
| Jun 5, 2018 | Shlevin Harold H.89 | Chief Operating Officer | Sale+OE | 20,831 | $5.15 | $107,356.26 | -16.2% | |
| Jun 4, 2018 | 10x Fund, L.P.85 | - | Sell | 50,000 | $5.12 | $256,080.93 | -0.8% |